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ABSTRACT 
This study was aimed at evaluating the antimicrobial activity of Moringa on ear, nose and throat associated fungi and 
vancomycin resistant cocci. The plant material was extracted with methanol and petroleum ethe and screened for phytochemical 
contents. The microbial isolates were obtained from females and males patients (both adults and children) attending ear, nose 
and throat clinic at Aminu Kano Teaching Hospital. Coccal bacteria and fungi were isolated accordingly. The cocci were screened 
for vancomycin resistance. The antimicrobial assay was carried out using gradient double (12.5-100mg/mL) assay. The MIC, 
MBC/MFC and Brine shrimp toxicity test were also conducted. Staphylococcus aureus, Streptococcus pyogenes, Streptococcus 
pneumoniae, Candida albicans and Aspergillus fumigatus were isolated. Up to 21.4% of S. aureus were vancomycin resistant, 20% 
of S. pneumoniae isolated were vancomycin resistant and 16.7% S. pyogenes were vancomycin resistant. The plant extracts showed 
zones of inhibition of 08mm-20mm at concentrations ranging from 12.5- 100mg/mL. The most susceptible organism to both 
extracts was C. albicans and the least susceptible was S. aureus. The MIC of the methanol extracts ranged from 0.78 to 50mg/mL 
but MBC/MFC ranged from 6.25 to 200mg/mL.  The MIC of the petroleum ether was at 50 to 200mg/mL  and the MBC/MFC was 
from 200 to 800mg/mL. The brine shrimp lethality assay showed LC50 value of 93.48µg/mL for Moringa methanol extract while the 
LC50 value for Moringa petroleum ether extract was 3.691µg/mL. Moringa methanol extract (100mg/mL), showed appreciable 
activity against the fungal isolates and vancomycin resistant cocci associated with Ear, Nose and Throat symptoms while Moringa 
petroleum ether extract showed activity only on the fungal isolate C. albicans. The study demonstrated that Moringa methanol 
extracts was more active than Moringa petroleum ether extracts. The search for novel cytotoxic ingredient in Moringa should be 
encouraged. 
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RÉSUMÉ 
Cette étude avait pour but d'évaluer l'activité antimicrobienne de Moringa sur l'oreille, nez et gorge champignons associés et 
cocci résistants à la vancomycine. L'usine a été extraite avec du méthanol et du pétrole ela et tamisée pour contenu 
phytochimique. Les isolats microbiens ont été obtenus à partir de les hommes et les patients (adultes et enfants) fréquentant 
l'oreille, nez et gorge clinique à l'Hôpital d'enseignement Aminu Kano. Coccal les bactéries et champignons ont été isolés en 
conséquence. Les coques ont été examinés pour la résistance à la vancomycine. L'antimicrobien a été réalisée à l'aide de double 
gradient 12.5-100(mg/mL). Le MIC, MBC/MFC et l'essai de toxicité d'artémia ont également eu lieu. Staphylococcus aureus, 
Streptococcus pyogenes, Streptococcus pneumoniae, Candida albicans et Aspergillus fumigatus étaient isolés. Jusqu'à 21,4 % 
des S. aureus étaient résistants à la vancomycine, 20 % de S. pneumoniae isolées étaient résistantes à la vancomycine et 16,7  % 
étaient S. pyogenes résistantes à la vancomycine. Les extraits de plantes ont montré des zones d'inhibition de 08mm-20mm à des 
concentrations variant de 12,5- 100mg/mL. Les plus sensibles à l'organisme les deux extraits a été C. albicans et le moins sensible 
était S. aureus. Le MIC de l'extrait au méthanol variait de 0,78 à 50 mg/mL mais MBC/MFC variait de 6,25 à 200mg/mL. Le MIC 
de l'éther de pétrole était à 50 à 200 mg/mL et le CBM/MFC a été de 200 à 800 mg/mL. La létalité d'artémia ont montré la valeur 
de LC50 93.48µg/mL pour le Moringa extrait méthanolique tandis que la CL50 pour le Moringa L'éther de pétrole extrait a été 
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3.691µg/mL. Le moringa extrait au méthanol (100mg/mL), a montré une activité appréciable contre les isolats fongiques et 
d'entérocoques résistants à la cocci associés à l'oreille, nez et gorge symptômes, tandis que l'éther de pétrole extrait de Moringa a 
montré que l'activité sur l'isolat fongique C. albicans. L'étude a démontré que les extraits de Moringa le méthanol a été plus 
active que l'éther de pétrole extrait de Moringa. La recherche de nouveaux ingrédients dans le Moringa cytotoxiques doivent 
être encouragés. 
 
INTRODUCTION                                                               
Medicinal plants have been used from ancient time for 
their medicinal values as well as to impact flavor to 
food. Nowadays, the crude extracts and dry powder 
samples from medicinal and aromatic plants species 
are used for the development and preparation of 
alternative medicine and food additives (1) .  Moringa, 
native to parts of Africa and Asia, is the sole genus in 
the flowering plant family Moringaceae. Important 
medicinal properties of the plant include antipyretic, 
antiepileptic, antiinflammatory, antiulcerative (2) , 
antihypertensive (3) cholesterol lowering (4) 
antioxidant (5) anti diabetic, hepatoprotective (6) , 
(antibacterial and antifungal activities (5). Vancomycin 
is an antibiotic used to treat a number of bacterial 
infections (7).  It is recommended intravenously as a 
first-line treatment for complicated skin infections, 
bloodstream infections, endocarditis, bone and joint 
infections, and meningitis caused by methicillin-
resistant Staphylococcus aureus (8). In addition to natural 
circumstances, misuse of vancomycin has led to 
vancomycin resistance. The reasons for clinical failure 
of vancomycin are many and have been hypothesized 
to include poor penetration of the drug to certain 
tissues (9, 10).Wide varieties of Ear, Nose and Throat 
diseases are usually presented to the Otorhinologist 
(head and neck surgeons) (11). The pattern of these 
diseases may vary from community to community or 
hospital to hospital based on the availability of 
specialist personnel or facilities for the management of 
such diseases which are either congenital or acquired 
in origin. Ear, nose and throat diseases are serious 
public health problems with universal distribution 
affecting all age groups (12). 
 
One of the research problems facing chemotherapy 
today is that microorganisms are now gaining 
resistance to vancomycin, which has been considered 
to be the reference standard for the treatment of 
bacterial infection. In Nigeria today, ear, nose and 
throat- related conditions constitute a major burden of 
infections. Yet the majority of the citizens are ignorant 
of ENT treatment options. Disease of the ear, nose 
and throat (ENT) affect the functioning of adults as 
well as children, often with significant impairment of 
the daily life of affected patients (13).  Due to the 
emergence of vancomycin resistance which is the last 
resort antibiotic where other antibiotics have failed 
and ignorance of the severity of ear, nose and throat 
infections, there is need for an easy, effective and 
affordable means to cure infections of the ear, nose 
and throat (ENT). Moringa is known for its numerous 
medicinal properties one of which is its antimicrobial 
activity (14). It is very common worldwide to find 
people consuming this plant in combination or alone 
as remedies against symptoms believed to be 
associated with the selected microorganisms targeted 
in this work. There is a need to find out if this plant 
has potent antimicrobial activity against ENT fungi 
and vancomycin resistant cocci. This plant is easy to 
afford. Moringa can be included in our foods and 
drinks e.g. tea and soups (15). 
  
MATERIAL AND METHODS 
Collection and Identification of Plant Materials 
The Moringa leaves were collected from Naibawa in 
Kano state. It was identified and compared to 
voucher specimen with voucher number (Moringa 
BUKHAN 0011) at the department of Plant Biology 
Bayero University, Kano Herbarium with the 
assistance of Baha’uddeen Said Adam(16). 
Processing and Extraction of Plant Materials 
The Moringa leaves were thoroughly washed with 
distilled water and air dried in a shady environment 
for two weeks and made into powdered form using a 
clean pestle and mortar, then it was sieved through a 
mesh to obtain fine powder of approximately 20µm 
particle size. The powder was stored at room 
temperature in sealed container until required for use 
as demonstrated(17).[ Accordingly, one hundred 
grams (100g) of the powdered plant material was 
extracted separately with methanol and petroleum 
ether using soxhlet apparatus as demonstrated (18). 
 Confirmation of the Bioactive Components of the 
Plants 
Phytochemical screening was carried out to confirm 
the bioactive components of the plant as follows: 
Test for Alkaloids 
This was carried out qualitatively as demonstrated 
(19).  Using a pipette, 1.0 ml of the extracts was placed 
in two separate test tubes. Using a dropper, three 
drops of Meyer’s reagent was added separately. A 
white precipitate with Meyer’s reagent indicated the 
presence of alkaloids. 
 
Test for Saponins 
This was carried out as demonstrated by the method 
reported (20).  0.5g each of the extracts was placed in 
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a test-tube, 5.0ml of sterile distilled water was added 
to the extract in the test-tubes and shaken vigorously. 
A froth that persisted for 15 minutes was an 
indication of the presence of saponins. 
 
Test for Steroids 
This was carried out as demonstrated by the method 
(19). 2g of each the extracts was placed in a test tube 
and evaporated to dryness. The extract was then 
dissolved in acetic anhydride followed by the 
addition of chloroform and then concentrated 
sulphuric acid was added by the side of the test tube. 
Appearance of a brown ring at the interface of the two 
liquids and the appearance of violet colour in the 
supernatant layer indicated the presence of steroids in 
the extract. 
Test for Reducing Sugar 
This was carried out as demonstrated by the method 
(20). Here, 1g each of the extracts was weighed and 
introduced into separate test tubes. The extracts were 
diluted with 2.0ml each of dimethyl sulphoxide 
(DMSO) and sterile distilled water respectively. 
Fehling’s solution was added to the solution obtained, 
and then the mixture was warmed. A brick-red 
precipitate at the bottom of the test tubes indicated 
the presence of reducing sugar. 
 
Test for Tannins 
2ml of each of the plant was diluted with distilled 
water in separate test tubes and 2-3 drops of 5% ferric 
chloride (fecl3) were added. A green-black or blue-
black colouration indicated the presence of tannin as 
demonstrated (19).  
  Test for Flavonoids 
This was carried out as demonstrated (21).  A 4mg 
weight of the extracts and a piece of magnesium 
ribbon were added together followed by concentrated 
HCL drop-wise. A colour change from crimson to 
magenta indicated the presence of flavonoids in the 
extracts. 
 
Test for Terpenoids 
0.5ml of the extracts was added to 2ml of chloroform, 
3ml of concentrated H2S04 was added to form a layer. 
A reddish brown colouration at the interface indicates 
the presence of terpenoids as demonstrated by the 
method (21) . 
Test for Anthraquinone 
0.5ml of the extract was taken into a dry test-tube and 
5ml of chloroform was added and shaken for 5mins. 
The extract was filtered and drops of ammonia 
solution were added. A pink violet or red colour in 
the ammonical layer (lower layer) indicates positive 
results. This is as demonstrated by the method (21). 
 
 
Tests for Phenol 
Few drops (0.5%) of dilute ferric chloride solution 
was added 0.5 ml of each of the extracts, the 
formation of a dark green colour shows the presence 
of phenol according to the method (22).   
 Collection and Identification of Test Isolates 
The isolation was carried out in Aminu Kano 
Teaching Hospital after ethical clearance has been 
approved. The isolation was carried out under the 
supervision of a medical laboratory technician. Thirty 
three specimens were collected from patients 
attending ENT clinic in any age group. The organisms 
were isolated from the ear, nose and throat swabs. 
The specimen was cultured on Sabouraud Dextrose 
Agar (Manufacturing date, 2016; Expiring date, 2018) 
for the isolation of fungi. After 3-7days of incubation 
the fungi isolates were identified macroscopically and 
microscopically with the help of scheme (23).   
 
The specimens were cultured on Chocolate agar for 
the isolation of cocci bacteria. The cocci were 
identified macroscopically in the culture plates after 
24 hours of incubation, after which gram staining was 
carried out. This was followed by catalase and 
coagulase test to confirm the species of Staphylococci. 
Optochin, bacitracin disc and bile solubility test were 
used to further confirm the species of streptococci. 
The identified cocci were subjected to vancomycin 
sensitivity disc (30µg) and the cocci that were found 
to be resistant to the vancomycin were used for this 
study as demonstrated (24). 
BIOASSAY  
Preparation of Extracts Concentrations 
This was carried out according to the method 
described by the method (25). Stock solution of 
moringa, methanol and petroleum ether crude 
extracts were prepared by dissolving 0.6g of each of 
the plant extracts in 6mL of dimetyhylsulphoxide 
(DMSO) in glass vial bottles. Therefore, each stock 
solution had concentration of 100000µg/mL 
(100mg/mL). The stock solution was double-diluted 
to get three varied extracts concentrations in addition 
to it to make them four different concentrations of 
100mg/mL, 50mg/mL, 25mg/mL and 12.5mg/mL 
(26). 
 Standardization of Inoculum 
The isolates were adjusted to 0.5 McFarland standard 
(1.5 X 108 CFU/mL) turbidity for bacteria isolates and 
1 x 106spores/mL for the fungi isolates by adding 
sterile normal saline. McFarland standards were used 
as a reference to adjust the turbidity of microbial 
suspension so that the number of microorganisms 
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will be within a given range. For the preparation of 
the 0.5 McFarland standard, 0.05mL of barium 
chloride (BaCl2) (1.17% w/v BaCl2.2H2O) was added 
to 9.95mL of 0.18M H2SO4 (1.0% w/v) with constant 
stirring. To aid comparison the standard was 
compared against a white background with a 
contrasting black line (27). 
 Preparation of Antibiotic Dilution 
The antibiotic ciprofloxacin and fluconazole were 
purchased from Lamco pharmacy Kano State, Nigeria 
and was reconstituted by dissolving 3g of the 
ciprofloxacin and fluconazole powder in 100ml of 
distilled water so as to get a concentration of 
30mg/mL. The prepared dilution of the antibiotics 
was used for subsequent antimicrobial test as positive 
control (21).[21] 
Antimicrobial Assay 
The bioassay was carried out using the agar well 
diffusion method described by cheesbrough (2006). 
0.1mL of the standardized inoculums (1.5 x 108 
CFU/ml) of Staphylococcus aureus was inoculated onto 
sterile prepared Mueller Hinton Agar and was spread 
with a sterile swab while Streptococcus pneumoniae was 
inoculated on chocolate agar and Streptococcus 
pyogenes was inoculated on sterile blood agar plates.   
 
Aspergillus fumigatus and Candida albicans were 
inoculated on sterile Sabouraud dextrose agar plates. 
Six wells were made with a 6mm sterile cork borer 
into the agar plates containing the bacterial and 
fungal inoculums and 0.lmL of the four different 
concentrations from the stock solution of the extracts 
at concentrations (100, 50, 25, and 12.5mg/mL) were 
introduced into their respective wells. 0.1mL of 
DMSO was introduced into the fifth well to serve as 
negative control while 0.1mL of 30mg/mL of 
ciprofloxacin was introduced into the sixth well to 
serve as a positive control for the bacterial isolates 
and fluconazole was used for the fungal isolates.  The 
inoculated plates were left to stand for about 30 
minutes to allow diffusion of extract before 
incubating at 37◦C for 24 hours for the bacterial 
isolates and the fungal isolates were incubated at 37oC 
for 3 days. The zones of clearance produced around 
the wells after incubation was observed and 
measured using a vernier caliper and recorded (in 
mm). Each of the experiment was conducted thrice 
and mean results were taken for the test organisms 
(28). 
 
Determination of Minimum Inhibitory 
Concentration, Minimum Bactericidal  and 
Fungicidal Concentration   
The minimum inhibitory concentration (MIC) is 
defined as the lowest concentration of the 
antimicrobial agent that inhibited visible growth of 
microorganisms after overnight incubation (Andrews, 
2002). The doubling macro dilution broth method was 
used to determine the MIC. Two (2) mL of the 
reconstituted crude extract at a concentration of 
100000µg/ml was added to 2mL sterile Mueller 
Hinton broth for the bacterial isolates, 2mL of the 
reconstituted crude extract was added to 2mL of 
Sabouraud dextrose broth for the fungal isolates. Two 
(2) mL of this extract concentration was transferred to 
another test-tube and this dilution continued until the 
12th test-tube was reached, giving extract 
concentrations ranging from 800-0.39mg/mL in 
different test tubes. 0.1mL of an 18h culture of 
bacteria and 3 days culture of fungi previously 
adjusted to 0.5 MacFarland standard was inoculated 
into each of the test tubes and the contents were 
thoroughly mixed.  A test tube containing the broth 
and extract was used as positive control while a test 
tube containing the broth and bacteria/fungal 
inoculum was used as negative control. The 
inoculated culture tubes were incubated at 37oC and 
were observed for growth after 24 hours for the 
bacterial isolates and 3days for the fungal isolates. 
The lowest concentration of extract showing no 
visible growth when compared with the control was 
considered as the MIC as demonstrated by the 
method (27).  
 
The minimum bactericidal/fungicidal concentration 
is the lowest concentration of antimicrobial agent that 
prevented the growth of an organism. 0.1mL aliquot 
from the tubes that showed no visible 
bacterial/fungal growth from the determination of 
minimum inhibitory concentration was inoculated on 
a sterile Mueller Hinton Agar for 24 hours at 37◦C for 
the bacterial isolate while the fungal isolates were 
inoculated on sterile Sabouraud dextrose agar at 37oC. 
The lowest concentration in which no growth 
occurred was taken as the minimum bactericidal 
concentration (MBC/MFC) as demonstrated (27). 
Assay for LC50 of the Plant Extracts by Brine Shrimp 
Lethality Test 
The eggs were hatched in a hatching chamber 
containing ocean sea salt water (75ml). Natural light 
was allowed to penetrate into the hatching chamber 
for 48 hours so that the eggs will hatch into the 
shrimp larvae. Twenty milligram (20mg) of the 
extracts were separately dissolved in 2ml of methanol 
and equally a positive control of which 20mg of the 
extracts was dissolved in 2ml of distilled water. 500, 
50 and 5ml of the solution equivalent to 1000, 100 and 
10 µg/mL respectively was transferred into vials. A 
negative control which is simply the solvent 
(methanol) without the test extracts was also 
prepared. Each concentration were tested in triplicate, 
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therefore each extracts had 9 test tubes. The methanol 
in the test tubes containing the extracts were allowed 
to evaporate to dryness for about 48 hours at room 
temperature and were subjected to test for their 
activity against Brine shrimp larvae (Artemia salina). 
To each test sample vial, sea water was added and a 
drop of DMSO solvent was added in order to 
facilitate the solubility of each test samples in the sea 
water. Ten (10) shrimps were transferred using a 
Pasteur pipette and natural sea water was added to 
make a total volume of 5ml. After 24 hours, the 
number of surviving shrimps at each concentration 
was counted and recorded. Lc50 values were 
determined at 95% confidence intervals by analyzing 
the data on a computer loaded with a “Finney 
Programme.” The Lc50 values of the brine shrimps 
obtained for extracts of the plants studied were 
recorded (29).  
  
RESULTS AND DISCUSSION 
Phytochemical Moringa Plant Extracts 
Some Phytochemical components of Moringa plant 
extracts are presented in Table 1. The data showed 
that, phenol, steroids, reducing sugar, flavonoid, 
terpenoids, tannins anthraquinone were present in 
both Moringa methanol and petroleum ether extracts. 
Alkaloid and saponin were present in Moringa 
methanol but absent in moringa petroleum ether 
extracts. 
Inhibitory Activity of the Moringa Extracts on ENT 
Associated Fungi and                  Vancomycin-
Resistant Cocci 
The inhibitory activity of Moringa on the test 
organisms is presented on Table 2. Moringa methanol 
extract showed zones of inhibition ranging from 8 – 
20mm at concentrations ranging from 12.5 – 
100mg/mL on the test organisms. However Moringa 
petroleum ether extract was not active on all the 
organisms except Candida albicans and at a 
concentration of 100mg/mL with a 09mm zone of 
inhibition. 
MIC and MBC/MFC of the Moringa Extracts on the 
Test Organisms   
The  MIC and MBC/MFC of the methanol and 
petroleum ether extracts on the test organisms is 
presented in  Table 3. From the data presented, the 
MIC for the test organism ranged from 0.78 to 
50mg/mL while the MBC/MFC ranged from 6.25 to 
200mg/mL. The MIC of the petroleum ether extracts 
ranged from 50 to 200mg/mL while the MBC/MFC 
ranged from 200 to 800mg/mL. 
Assay for the LC50 of Moringa extracts by Brine 
Shrimp Lethality Test  
Brine shrimp lethality toxicity assay of the plant 
extracts is presented in table 4. The brine shrimp 
results in this study are interpreted as follows: LC50 
<1.0 µg/mL – highly toxic; LC50 1.0-10.0 µg/mL – 
toxic; LC50 10.0-30.0 µg/mL – moderately toxic; LC50 
>30 <100µg/mL – mildly toxic, and > 100µg/ml as 
non-toxic (Moshi et al., 2010). From the data presented 
in table 4, the LC50 for MME is 93.48µg/mL while the 
LC50 MPE is 3.691µg/mL, From this result, MPE is 
toxic while MME is mildly toxic. 
 
In this study Moringa methanol was found to be more 
active than moringa petroleum ether extract. Moringa 
methanol inhibited the growth of all the organisms it 
was tested on. Moringa petroleum ether extract on the 
other hand inhibited only the growth of Candida 
albicans at a concentration of 100mg/mL which gave a 
09mm zone of inhibition. However when the 
concentration was increased from 200-800mg/mL it 
was found to inhibit the growth of the organisms and 
it also had bactericidal and fungicidal effect. A similar 
study was conducted and moringa leaf petroleum 
ether extract was found to be active at this same 
concentration as reported (26). It was also revealed in 
this study that moringa methanol extract possessed 
all the phytochemicals it was screened for. Alkaloids 
and saponins were absent in moringa petroleum ether 
extracts, this could be the reason for its poor activity. 
However, a similar research carried out (30), reported 
the presence of Alkaloid and Saponin but in low 
amount. Alkaloids are naturally occurring chemical 
compounds containing basic nitrogen atoms. They 
often have pharmacological effects and are used as 
medications and recreational drugs (31).  Saponins 
cause hemolysis of red blood cells (32). 
 
TABLE 1: PHYTOCHEMICAL COMPONENTS OF 
MORINGA IDENTIFIED 
 
Test   MME MPE 
Phenols + + 
Alkaloids + - 
Saponins + - 
Steroids + + 
Reducing Sugar + + 
Flavonoids + + 
Tannins + + 
Terpenoids + + 
Anthraquinone + + 
KEY:, MME= Moringa Methanolic Extract, MPE= Moringa 
Petroleum Ether Extract; + = Presence of Secondary 




TABLE 2: INHIBITORY ACTIVITY OF MORINGA (MORINGA OLEIFERA) EXTRACTS ON ENT FUNGI AND 
VANCOMYCIN RESISTANT COCCI 
  








100  50  25  12.5 
10   08  00   00 
100  50  25 12.5 





S. pyogenes 14  11  08    08  00    00  00   00 00 25 
S. pneumonia 10  08  08    00  00    00  00   00 00 28 
A. fumigates 19  12  12    10  00    00  00   00 00 00 
C. albicans  20  16  10    00  09    00  00   00 00 10 
KEY: DMSO= Dimethyl sulfoxide, Cip= Ciprofloxacin, Flu= Fluconazole, MME = Moringa methanol extract, MPE = Moringa 
petroleum ether extra 
 
TABLE 3: MIC AND MBC/MFC OF THE METHANOL 
AND PETROLEUM ETHER EXTRACTS ON ENT FUNGI 













S. aureus 50 100 200 800 
S. pyogenes 50 200 100 200 
S. 
pneumoniae 
6.25 50 100 400 
A. fumigatus 6.25 25 100 200 
C. albicans 0.78 6.25 50 200 
  
KEY: MIC= Minimum Inhibitory Concentration, 
MBC/MFC = Minimum Bactericidal 
Concentration/Minimum Fungicidal Concentration 
 








MME 1000 11 26.7 93.48 
 100 22 6.7  
 10 28 53.3  
MPE 1000 14 46.7 3.691 
 100 16 26.7  
 10 22 26.7  
KEY:    MME = Moringa methanol extract,      MPE = 
Moringa petroleum ether extra 
 
RECOMMENDATIONS 
1. The study demonstrated that Moringa 
extracts was active, therefore, the 
search for the novel cytotoxic 
ingredients in Moringa should be 
encouraged.  
2. Individual compounds of the plants 
should be isolated, purified, 
characterized and tested.  
3. Other solvents and extraction method 
should be used for the extraction of 
the plant material to see if the 
performance of the extracts will be 
better.  
4. The plant extracts should be 
evaluated in vitro to ascertain their 
activity on ear, nose and throat fungi 
and vancomycin resistant cocci and 
also to evaluate their effect on vital 
organs of the body.  
5. Combination of Moringa with 
plants with lower toxicity should be encouraged. 
 
CONCLUSION 
The present study deduced that, Moringa methanol 
extract was more active than Moringa petroleum 
ether extracts, although Moringa petroleum ether 
extract was experimentally more active on C. albicans 
than on vancomycin resistant coccal bacteria. 
Aspergillus fumigatus was the most predominant 
fungus while Staphylococcus aureus was the most 
predominant cocci associated with ENT at the time of 
this study. Moringa methanol extract was more active 
on S. aureus, S. pyogenes, S. pneumoniae, Aspergillus 
fumigatus and C. albicans.   
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